Daniel Thompson Selected Research

Daniel Thompson Research Topics

2	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2023
2	Inflammation (Inflammations) 04/2021 - 03/2012
1	Hypercalcemia (Milk Alkali Syndrome) 09/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Aneurysm (Aneurysms) 01/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Primary Hyperparathyroidism 11/2021
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2021
1	Neoplasms (Cancer) 05/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2021
1	Lymphoma (Lymphomas) 05/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2021
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Fistula 01/2021
1	Infections 07/2014
1	Dyslipidemias (Dyslipidemia) 03/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2012
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2012
1	Bacterial Vaginosis 07/2005
1	Vulvovaginal Candidiasis 07/2005

2	AntigensIBA 12/2023 - 11/2023
1	PotassiumIBA 09/2023
1	CreatinineIBA 09/2023
1	GlucocorticoidsIBA 09/2023
1	Serum AlbuminIBA 09/2023
1	MineralocorticoidsIBA 09/2023
1	ORALIT (ORS)IBA 01/2023
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 11/2021
1	fluorocholineIBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2014
1	Metformin (Glucophage)FDA LinkGeneric 03/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2012
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2012
1	clindamycin phosphate (Clindets)FDA LinkGeneric 07/2005
1	butoconazole (Femstat)FDA Link 07/2005

1	Prostatectomy (Retropubic Prostatectomy) 12/2023
1	Lymph Node Excision (Lymph Node Dissection) 12/2023
1	Castration 11/2023
1	Parathyroidectomy 11/2021
1	Stents 01/2021
1	Therapeutics 03/2012